NASDAQBEAM

Biotechnology company developing precision genetic medicines – Beam Therapeutics (NASDAQ:BEAM) said that its CFO, Terry-Ann Burrell, will be leaving the company effective August 9, 2024. She will be pursuing a new opportunity as vice chairman of investment banking at JPMorgan Chase. As part of a transition process, the company hasContinue Reading